NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Huma

Huma

Private
LondonHealthcare & Life Scienceshttps://www.huma.com/

Last Round

Early Funding

Sep 13, 2024

Est. Valuation

$1B

Total Funding Raised

$335M

Company Overview

Huma is a healthcare technology company that provides a digital-first platform for remote patient monitoring, decentralized clinical trials, and AI-driven healthcare workflows.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Telemedicine, Medical AI, Patient Engagement, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

remote patient monitoringRPMdecentralized clinical trialsDCTclinical documentationgenerative AIdigital health platformAI scribeclinical billingdigital-first carehealth operating systemEHR integrationpatient engagementusage-based billingAI-native healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Huma Comparables

Compare Huma with similar companies based on industry and business-model similarity.

Huma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biofourmis
85%
Medable Inc
78%
BrightInsight
78%

Huma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 13, 2024
Series DJul 16, 2024
StrategicMar 23, 2022
Series CMay 11, 2021
M&AApr 16, 2020
Series B
Nov 5, 2019

Key People

Founding team and executive leadership

Dan Vahdat

CEO Founder

Founding Team

Hamid Rafieian

Field CEO

Executive Team

Reza Mogharab

Deputy Field CEO

Executive Team

Ryan Sedigh

Field CEO

Executive Team

Huma Investors

Notable investors and investment history

Huma investors
InvestorRounds
Stellar Development FoundationEarly Funding
Sony Ventures CorporationSeries C
Dale VenturesSeed
HV FundSeries C, Series D
NWS HoldingsSeries B, Series A
Distributed GlobalEarly Funding
Samsung NEXT VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 5, 2025

    Launched Hi Scribe, a generative AI clinical documentation tool.

  • May 19, 2025

    Acquired Aluna to expand US presence.

Huma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Huma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Huma's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range278
Year Founded2011
Last FundingSep 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.